Analysis of Glucose Responses to Automated Insulin Suspension With Sensor-Augmented Pump Therapy

OBJECTIVE: The advent of sensor-augmented pump therapy with a low-glucose suspend (LGS) function (Medtronic Paradigm Veo System), allowing insulin to be automatically suspended for up to 2 h when sensor glucose falls below a preset threshold, has the potential to reduce the duration of hypoglycemia....

Descripción completa

Detalles Bibliográficos
Autores principales: Ly, Trang T., Nicholas, Jennifer A., Retterath, Adam, Davis, Elizabeth A., Jones, Timothy W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3379608/
https://www.ncbi.nlm.nih.gov/pubmed/22584133
http://dx.doi.org/10.2337/dc12-0052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3379608/
https://www.ncbi.nlm.nih.gov/pubmed/22584133
http://dx.doi.org/10.2337/dc12-0052

Ejemplares similares